-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
ZimVie (NASDAQ:ZIMV) Coverage Initiated by Analysts at Barclays
ZimVie (NASDAQ:ZIMV) Coverage Initiated by Analysts at Barclays
Barclays began coverage on shares of ZimVie (NASDAQ:ZIMV – Get Rating) in a research report report published on Wednesday, The Fly reports. The brokerage issued an underweight rating and a $9.00 target price on the stock.
ZimVie Price Performance
NASDAQ:ZIMV opened at $8.52 on Wednesday. The business's 50-day moving average price is $8.68 and its 200 day moving average price is $13.30. ZimVie has a 52-week low of $6.67 and a 52-week high of $50.40. The company has a quick ratio of 1.48, a current ratio of 2.51 and a debt-to-equity ratio of 0.76.
Get ZimVie alerts:ZimVie (NASDAQ:ZIMV – Get Rating) last released its earnings results on Wednesday, November 9th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.27 by $0.22. The firm had revenue of $214.58 million for the quarter, compared to analyst estimates of $214.83 million. ZimVie had a negative return on equity of 2.75% and a negative net margin of 9.96%. As a group, sell-side analysts predict that ZimVie will post 1.95 EPS for the current fiscal year.
Hedge Funds Weigh In On ZimVie
A number of institutional investors have recently bought and sold shares of the stock. Point72 Hong Kong Ltd purchased a new position in ZimVie in the 3rd quarter worth about $27,000. US Bancorp DE acquired a new stake in ZimVie during the 3rd quarter worth about $36,000. Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in ZimVie during the 3rd quarter worth about $46,000. Tower Research Capital LLC TRC acquired a new stake in ZimVie during the 3rd quarter worth about $47,000. Finally, Strs Ohio acquired a new stake in ZimVie during the 3rd quarter worth about $47,000. Hedge funds and other institutional investors own 74.29% of the company's stock.ZimVie Company Profile
(Get Rating)
ZimVie Inc, a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies.
Read More
- Get a free copy of the StockNews.com research report on ZimVie (ZIMV)
- MarketBeat: Week in Review 12/19 – 12/23
- These Steelmakers Deserve A Place On Your 2023 Watch List
- Inflation Cools, Where Does The S&P 500 Go Now
- Cintas Beats Inflation With Operating Leverage
- Your Decision to Buy Palantir May Simply Be a Matter of Time
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.
Barclays began coverage on shares of ZimVie (NASDAQ:ZIMV – Get Rating) in a research report report published on Wednesday, The Fly reports. The brokerage issued an underweight rating and a $9.00 target price on the stock.
據The Fly報道，巴克萊在週三發佈的一份研究報告中開始報道ZimVie(納斯達克：ZIMV-GET Rating)的股票。該經紀公司對該股發佈了減持評級和9.00美元的目標價。
ZimVie Price Performance
ZimVie性價比
NASDAQ:ZIMV opened at $8.52 on Wednesday. The business's 50-day moving average price is $8.68 and its 200 day moving average price is $13.30. ZimVie has a 52-week low of $6.67 and a 52-week high of $50.40. The company has a quick ratio of 1.48, a current ratio of 2.51 and a debt-to-equity ratio of 0.76.
納斯達克：ZIMV週三開盤報8.52美元。該業務的50日移動均線價格為8.68美元，200日移動均線價格為13.30美元。ZimVie的52周低點為6.67美元，52周高點為50.40美元。該公司的速動比率為1.48，流動比率為2.51，債務權益比率為0.76。
ZimVie (NASDAQ:ZIMV – Get Rating) last released its earnings results on Wednesday, November 9th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.27 by $0.22. The firm had revenue of $214.58 million for the quarter, compared to analyst estimates of $214.83 million. ZimVie had a negative return on equity of 2.75% and a negative net margin of 9.96%. As a group, sell-side analysts predict that ZimVie will post 1.95 EPS for the current fiscal year.
津維(納斯達克：ZIMV-GET評級)最近一次發佈收益報告是在11月9日星期三。該公司公佈本季度每股收益(EPS)為0.49美元，高於分析師普遍預期的0.27美元和0.22美元。該公司本季度營收為2.1458億美元，而分析師預期為2.1483億美元。ZimVie的淨資產回報率為負2.75%，淨利潤率為負9.96%。賣方分析師預測，作為一個整體，ZimVie本財年的每股收益將達到1.95美元。
Hedge Funds Weigh In On ZimVie
對沖基金對ZimVie的看法
ZimVie Company Profile
ZimVie公司簡介
(Get Rating)
(獲取評級)
ZimVie Inc, a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies.
ZimVie公司是一家醫療技術公司，開發、製造和提供一系列產品和解決方案，旨在治療一系列脊柱疾病，並在全球範圍內支持牙齒替換和修復程式。它提供牙科植入系統、假體和基臺產品、手術器械和套件；骨移植、屏障膜、同種異體移植和膠原傷口護理產品；口腔內掃描儀；虛擬治療計劃服務、指導性手術解決方案、CAD/CAM工作流程系統、患者特定的修復部件和口腔內掃描儀，以及用於各種脊柱程式、生物製劑和骨癒合技術的脊柱融合植入物和器械。
Read More
閱讀更多內容
- Get a free copy of the StockNews.com research report on ZimVie (ZIMV)
- MarketBeat: Week in Review 12/19 – 12/23
- These Steelmakers Deserve A Place On Your 2023 Watch List
- Inflation Cools, Where Does The S&P 500 Go Now
- Cintas Beats Inflation With Operating Leverage
- Your Decision to Buy Palantir May Simply Be a Matter of Time
- 免費獲取StockNews.com關於ZimVie的研究報告(ZIMV)
- MarketBeat：回顧一週12/19-12/23
- 這些鋼鐵制造商理應在2023年觀察名單上佔有一席之地
- 通脹降溫，標普500指數何去何從
- Cintas以經營槓桿擊敗通脹
- 你買下Palantir的決定可能只是個時間問題
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.
接受ZimVie Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對ZimVie和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧